MICROCAP LIQUIDATING TRUST
10-K, 1998-03-30
Previous: NETBANK INC, 10-K405, 1998-03-30
Next: FIRST NATIONAL COMMUNITY BANCORP INC, 10-K, 1998-03-30



                                             SECURITIES AND EXCHANGE COMMISSION
                                                     Washington, D.C. 20549
                                                            FORM 10-K


[   ]    Annual Report Pursuant to Section 13 or 15(d) of the Securities 
          Exchange Act of 1934

For the Fiscal Year Ended

Or

[X]      Transition Report Pursuant to Section 13 or 15(d) of the Securities 
          Exchange Act of 1934

For                          the  transition  period from  February  25, 1997 to
                             December 31, 1997 Commission file number 0-29120

                                                 MICROCAP LIQUIDATING TRUST
                                         (Successor to The MicroCap Fund, Inc.)
================================================================================
                         (Exact Name of Registrant as Specified in its Charter)

New York                                                             13-7110611
===============================================================================
(State or Other Jurisdiction of            (I.R.S. Employer Identification No.)
Incorporation or Organization)

c/o Raymond S. Troubh
Ten Rockefeller Plaza, Suite 712
New York, New York                                                     10020
==============================================================================
(Address of Principal Executive Offices)                             (Zip Code)

Registrant's Telephone Number, Including Area Code:  (800) 888-6534

Not applicable
===============================================================================
Former name, former address and former fiscal year, if changed since last report

Securities registered pursuant to Section 12(b) of the Act:

          Title of each class      Name of each exchange on which registered
                 None                             None

Securities registered pursuant to Section 12(g) of the Act:

                                                  Units of Beneficial Interest
================================================================================
                                                        (Title of class)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No
                                             (Cover page continues on next page)


<PAGE>


Indicate by check mark if disclosure of delinquent  filers  pursuant to Item 405
of Regulation  S-K is not contained  herein,  and will not be contained,  to the
best of Registrant's  knowledge,  in definitive proxy or information  statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ X ]

As of March 16, 1998,  there were 2,427,281 units of beneficial  interest of the
MicroCap Liquidating Trust outstanding.



                                             Documents Incorporated By Reference

                                                              None


<PAGE>


                                                             PART I
Item 1.       Business.

General

The MicroCap  Liquidating  Trust (the "Trust"),  a liquidating trust established
under the laws of the State of New York, is the successor to The MicroCap  Fund,
Inc., formerly Commonwealth Associates Growth Fund, Inc. (the "Fund"). The Fund,
which  was  a  Maryland   corporation   formed  on  January  26,  1993,   was  a
non-diversified,  closed-end  management  investment  company and  operated as a
business  development  company  under the  Investment  Company Act of 1940.  The
Fund's investment  objective was to achieve  long-term  capital  appreciation of
assets,  rather than current income,  by investing in debt and equity securities
of  emerging  and  established   companies  that  management   believed  offered
significant growth potential.

Pursuant to its Plan of Liquidation,  which was approved at a special meeting of
shareholders  on July 23,  1996,  the Fund  transferred  all of its existing and
contingent  assets and  liabilities  to the Trust,  effective as of the close of
business on February 24, 1997.

Also  effective as of the close of business on February 24, 1997,  the 2,188,085
common  shares and 191,357  preferred  shares of the Fund,  outstanding  on such
date,  were  automatically  deemed to represent  2,427,281  units of  beneficial
interest in the Trust (the  "Units").  As a result,  on February 24, 1997,  each
shareholder  of the Fund  received  one Unit of the Trust for each  share of the
Fund's common stock held on such date and 1.25 Units of the Trust for each share
of the Fund's preferred stock held on such date.

The Trust was  organized for the sole purpose of  liquidating  the Fund's assets
and  winding up the Fund's  affairs.  The Trust  will  terminate  upon the final
liquidation of its remaining assets, payment of all liabilities and satisfaction
of all outstanding claims and contingencies.

Cash Distributions

On August 30,  1996,  the Fund made an  initial  liquidating  cash  distribution
totaling  $8,495,486  to  shareholders  of  record on August  15,  1996.  Common
shareholders received $3.50 per share and preferred shareholders received $4.375
per share.  The amount paid to common  shareholders  was  comprised of $0.274 of
long-term  capital  gain and $3.226 of return of  capital.  The  amount  paid to
preferred  shareholders  was  comprised of $0.343 of long-term  capital gain and
$4.032 of return of capital.

On July 15 1997, the Trust paid an interim liquidating  distribution  totaling 
$2,427,281,  or $1.00 per Unit, to unit holders of record on June 30, 1997.

Portfolio Investments
On  December  31,  1997,  the Trust  held  four  portfolio  investments  with an
aggregate cost of $2,177,500  and a fair value of $1,622,500.  During the period
from  February  25, 1997 to December  31,  1997 (the "1997  Period"),  the Trust
liquidated its investment in Bennett  Environmental,  Inc. and sold a portion of
its investment in Unigene  Laboratories,  Inc. These transactions,  discussed in
more detail  below,  resulted in a net  realized  gain of $775,250  for the 1997
Period.

In June 1997, the Trust sold a covered call option for $37,500, allowing for the
purchase of up to 307,500 common stock warrants of Unigene Laboratories, Inc. at
a purchase  price of $2.875 per  warrant.  In July 1997, a portion of the option
was  exercised  for 140,000  warrants at $2.875 per warrant,  or  $402,500.  The
remaining  portion of the option  expired on July 30, 1997. The Trust realized a
net gain of $440,000 as a result of these transactions.

In November 1997, the Trust sold its remaining  112,500 common shares of Bennett
Environmental,  Inc. for net proceeds of $382,500, or $3.40 per share. The Trust
realized a net gain of $335,250 as a result of this sale.

Competition

The Trust is operating  solely to liquidate  its  remaining  assets and will not
invest in any new portfolio companies, therefore, the Trust is not competing for
new investment opportunities.

Employees
     The Trust has no employees.  In July 1996,  Raymond S. Troubh was appointed
President,  Chief Executive  Officer,  Treasurer,  Secretary and Director of the
Fund. All of the Fund's previous  officers and all of its employees had resigned
by the end of July 1996.  Mr. Troubh held these offices  through the Fund's date
of termination and became the independent liquidating trustee of the Trust, with
primary responsibility for the liquidation of its remaining assets.

Item 2.       Properties.

None

Item 3.       Legal Proceedings.

On April 19, 1996, the Fund filed a complaint against Commonwealth Associates, a
registered  broker-dealer  and the  underwriter  of the  Fund's  initial  public
offering,   Michael  S.  Falk,  the  chief  executive  officer  of  Commonwealth
Associates,  a minority shareholder and former director of the Fund, and Stephen
J. Warner, a former executive officer of Commonwealth  Associates and the former
president of the Fund. The civil action, which was filed in federal court in the
Southern  District of New York,  alleged fraud,  breach of fiduciary  duties and
violations of the Investment Company Act of 1940. On December 24, 1996, the Fund
and the defendants agreed to a settlement of the complaint, whereby Commonwealth
Associates  made  settlement  payments  to  the  Fund  and  the  Trust  totaling
$1,150,000. In connection therewith, the Fund received $500,000 in December 1996
and an additional  $650,000 in installments during 1997. Interest of $20,415 was
also paid to the Trust  with the final  installment  payment in  December  1997.
Additionally,  as part of the settlement,  the Fund and the defendants agreed to
pursue  claims  against  former  counsel to the Fund.  The Trust is  entitled to
receive 50% of any recovery from such claims after reimbursement to Commonwealth
Associates of all costs and expenses associated with pursuing the claims.

The Trust is a creditor of PSSS, Inc., formerly Oh-La-La!  Inc. ("PSSS"),  which
is the subject of proceedings  under Chapter 11 of the United States  Bankruptcy
Code pending in San Francisco, California (the "Bankruptcy Case"). In connection
with the Bankruptcy Case, Oh-La-La! International,  S.A. ("International"),  one
of PSSS's largest  shareholders,  has filed a precautionary  proof of claim (the
"Precautionary  Proof of Claim"), on behalf of International and other similarly
situated  shareholders of PSSS, against,  among others, the Trust, certain other
creditors of PSSS, and parties  involved in the intended  underwriting  for, and
conduct of, an initial  public  offering which PSSS had  anticipated  would have
occurred in or about 1994. The Precautionary  Proof of Claim alleges a claim for
damages as a result of, among other things,  (a) the failure to  effectuate  the
intended initial public offering, and (b) the Bankruptcy  Court-approved sale of
PSSS's assets, which was allegedly prejudicial to PSSS's shareholders.  PSSS and
International  have taken no other action regarding this claim. The Trust denied
liability for the claims set forth in the Precautionary Proof of Claim. A global
settlement has been reached between and among PSSS, International, the Trust and
several  other  parties,  pursuant to which the Trust will have no liability for
the claims set forth in the Precautionary Proof of Claim (the "Settlement"). The
Settlement  has been  preliminarily  approved  by the  Bankruptcy  Court  and is
subject to final approval upon  confirmation  of a plan of liquidation for PSSS.
Recovery  on account of the Trust's  claims as a creditor of PSSS is  contingent
upon a number of factors beyond the Trust's control.

Regency  Holdings   (Cayman)  Inc.   ("Holdings")  and  Regency  Maritime  Corp.
("Maritime")  (collectively  "Regency")  along with other  related  entities are
debtors in a bankruptcy case pending in the United States  Bankruptcy  Court for
the Southern  District of New York, 95 B 45197 (TLB). In that  bankruptcy  case,
Regency  initiated an adversary  proceeding  against the Fund and certain  other
persons and entities to recover monies that it paid them on the ground that such
payments constituted  voidable  preferences or fraudulent  conveyances under the
Bankruptcy Code.  Holdings  maintains that a payment made to the Fund between 90
days and one year prior to the filing of  Regency's  bankruptcy  petition in the
amount of  $1,940,000  to satisfy a bridge loan the Fund made to  Regency,  is a
voidable preference because Kamal Mustafa, the former president of the Fund, was
a director of Regency (and  therefore an insider) for a portion of the time that
such amounts were due and owing.  Holdings also maintains that such relationship
had an  impact on the  decision  to pay these  amounts.  Additionally,  Holdings
maintains that a payment of $145,728 made to the Fund to redeem certain warrants
issued  with  respect  to the loan  transaction  was made  within 90 days of the
filing of the bankruptcy petition and is therefore a voidable preference without
regard to whether Mustafa was an insider.  The Fund has served an answer denying
the allegations of the amended complaint and is vigorously  contesting Regency's
claims.  Pursuant to an order filed with the Bankruptcy Court, the Trust has set
aside  approximately  $2.4 million in an  interest-bearing  cash account pending
resolution  by the  Bankruptcy  Court of the adversary  proceeding.  Substantial
discovery has been undertaken. A limited trial based upon written submissions to
address the validity of Regency's  preference  claims was held in December  1997
and  resulted in a judgment  in favor of the Trust,  dismissing  the  preference
claims with prejudice.  It is expected that a trial on the fraudulent conveyance
claims will be held during 1998.

Item 4.       Submission of Matters to a Vote of Security Holders.

No matter was submitted to a vote of Unit holders during the last quarter of the
period covered by this report.
                                                             PART II

Item 5.   Market for Registrant's Common Equity and Related Stockholder Matters.

There were 2,427,281  units of beneficial  interest of the MicroCap  Liquidating
Trust (the "Units") outstanding as of March 16, 1998. Units of the Trust (CUSIP#
59501M) became listed  securities on the OTC Bulletin Board for over-the counter
securities as of April 30, 1997.

The following table sets forth, for each of the periods indicated,  the high and
low closing bid prices for the Units as reported by NASDAQ since April 30, 1997.
These per Unit quotations represent  inter-dealer prices on the over-the-counter
market,  do not include retail  markups,  markdowns,  or commissions and may not
represent actual transactions.

<TABLE>
                                                                                 Price Per Unit
                                                                           High                   Low
Period from April 30, 1997 to December 31, 1997:
<S>       <C> <C>          <C> <C>                                       <C>                   <C>     
    April 30, 1997 to June 30, 1997                                      $   2.25              $   0.38
    Third quarter                                                            2.13                  0.69
    Fourth quarter                                                           1.19                  0.75
    Period from January 1, 1998 to March 16, 1998                            1.00                  0.81
</TABLE>

As of March 16, 1998,  there were 9 Unit holders of record of the Trust.  
Certain holders of record held Units for  approximately 255 beneficial owners.


<PAGE>


Item 6.       Selected Financial Data.


<TABLE>
                                                                  Period From                                           Period From
                                                                Mar. 1, 1996 to      Fiscal Year     Fiscal Year       Mar. 19, 1993
                                              Period From        Feb. 24, 1997       Ended             Ended          (Commencement
                                             Feb. 25, 1997         (Date of           Feb. 29,        Feb. 28,     of Operations) to
                                              to Dec. 31,        Termination)           1996             1995         Feb. 28, 1994
                                                 1997            (Predecessor)      (Predecessor)   (Predecessor)      (Predecessor)
                                           ---------------       ------------       ------------    ------------    ----------------

Operating Data:
Net ivestment income (loss) (interest and
<S>                                               <C>                <C>                <C>               <C>                <C>   
dividend income less operating expenses)   $    (173,067)     $   (1,243,927)    $    (313,174)    $    220,352       $      55,079

Net realized gain (loss) from portfolio investments775,250          3,972,372        (1,061,009)        (161,149)        (1,557,030)

Change in net unrealized appreciation or
   (depreciation) of investments                (1,026,843)         (1,684,806)        2,121,261          548,448          (513,060)

Net realized and unrealized gain (loss) from
   portfolio investments                          (251,593)          2,287,566         1,060,252          387,299        (2,070,090)

Net increase (decrease) in net assets resulting
   from operations                                (424,660)          1,043,639           747,078          607,651        (2,015,011)

Cash distributions                               2,427,281           8,495,486                 -          440,800                  -

Per Unit or Common Equivalent Share*:
Net investment income (loss)                   $     (.07)          $     (.51)        $    (.13)        $    .10           $    .03

Net realized and unrealized gain (loss) from
   portfolio investments                             (.10)                 .94               .44              .18              (.94)

Net increase (decrease) in net assets resulting
   from operations                                  (.17)                 .43               .31              .28               (.91)

Cash distributions                                  1.00                 3.50              -                 .20               -


                                                               Feb. 24, 1997
                                                                 (Date of
                                                             Termination)       Feb. 29, 1996     Feb. 28, 1995       Feb. 28, 1994
                                        Dec. 31, 1997        (Predecessor)      (Predecessor)     (Predecessor)       (Predecessor)
Balance Sheet Data:
Total assets                              $    7,084,047       $   10,968,644    $   17,568,711   $   18,054,440     $    17,739,168

Net assets                                     6,931,370            9,783,311        17,235,158       17,715,073          17,548,222

Cash and cash equivalents                      5,442,020            7,571,246         9,878,280        9,033,750           4,475,544

Portfolio investments at fair value            1,622,500            2,696,593         6,939,805        8,371,350          11,645,538

Per Unit or Common Equivalent Share**:
Net assets                                    $     2.86           $     4.03         $    7.25        $    8.04           $   7.96
</TABLE>

* Based  on  weighted  average  number  of  Units or  common  equivalent  shares
outstanding  for each respective  period.  ** Based on number of Units or common
equivalent shares outstanding as of the period end date.


<PAGE>


Item 7.       Management's Discussion and Analysis of Financial Condition and 
               Results of Operations.

Liquidity and Capital Resources

On December 31, 1997, the MicroCap  Liquidating Trust (the "Trust") had cash and
cash equivalents totaling  $5,442,020,  of which $2,790,218 is restricted due to
certain  contingencies,  as  discussed  below.  The Trust's  cash  balances  are
invested   in  U.S.   Treasury   Bills  or   overnight   repurchase   agreements
collateralized  by  securities  issued by the U.S.  Government  or its agencies.
Interest  earned from such  investments for the period from February 25, 1997 to
December 31, 1997 (the "1997 Period")  totaled  $270,147.  Interest  earned from
such investments  held by The MicroCap Fund, Inc. (the "Fund"),  the predecessor
entity to the Trust, for the period from March 1, 1996 to February 24, 1997, the
Fund's  termination date,  ("Fiscal 1997") and for the period from March 1, 1995
to  February  28,  1996  ("Fiscal   1996"),   totaled   $450,528  and  $444,621,
respectively  .  Interest  earned from such cash  equivalent  balances in future
periods is subject to fluctuations  in short-term  interest rates and changes in
cash equivalent balances held by the Trust.

The restricted cash and cash equivalents  balance of approximately  $2.8 million
at  December  31,  1997 is  comprised  of $2.4  million  relating to the Regency
Holdings (Cayman) Inc. litigation,  $250,000 relating to certain indemnification
agreements with Mr. Raymond S. Troubh,  the Trustee of the Trust, and certain of
the Fund's former directors and officers and $120,000  relating to the potential
reimbursement  of  out-of-pocket  expenses  of  a  shareholder  group  that  had
solicited  proxies in opposition to the Fund's Plan of Liquidation.  See Notes 4
and 5 of the Notes to Financial Statements for additional information.

On July 15, 1997, the Trust paid an interim  liquidating  distribution  totaling
$2,427,281,  or $1.00 per Unit, to unit holders of record on June 30, 1997.  The
Trust expects to make  additional cash  distributions  to  beneficiaries  as its
remaining assets are liquidated,  subject to maintaining an adequate reserve for
all current and contingent liabilities.

Results of Operations

Realized and Unrealized  Gains and Losses from  Portfolio  Investments - For the
1997 Period, the Trust had a net realized and unrealized loss from its portfolio
investments  of $251,593.  For Fiscal 1997 and Fiscal  1996,  the Fund had a net
realized and  unrealized  gain from its portfolio  investments of $2,287,566 and
$1,060,252, respectively.

1997 Period:
The $251,593 net realized and unrealized  loss for the 1997 Period was comprised
of a $775,250 net realized gain from the sale of certain  portfolio  investments
during the 1997 Period, as discussed below.  These realized gains were more than
offset by a  $1,026,843  decrease to net  unrealized  appreciation  of portfolio
investments during the 1997 Period, as discussed below.

In June 1997, the Trust sold a covered call option for $37,500, allowing for the
purchase of up to 307,500 common stock warrants of Unigene Laboratories, Inc. at
a purchase  price of $2.875 per  warrant.  In July 1997, a portion of the option
was  exercised  for 140,000  warrants at $2.875 per warrant,  or  $402,500.  The
remaining  portion of the option  expired on July 30, 1997. The Trust realized a
net gain of $440,000 as a result of these  transactions.  In November  1997, the
Trust sold its remaining  112,500 common shares of Bennett  Environmental,  Inc.
for $382,500, or $3.40 per share, resulting in a realized gain of $335,250.

During the 1997  Period,  the Trust had a  $1,026,843  net  decrease  in the net
unrealized  appreciation of its remaining portfolio  investments.  Such decrease
included a $623,438 net downward  revaluation of the Trust's holdings of Unigene
Laboratories,  Inc.,  and a net  transfer of $403,405  from  unrealized  gain to
realized gain relating to the portfolio investments sold during the 1997 Period,
as discussed above.


<PAGE>


Fiscal 1997:
The Fund's  $2,287,566  net  realized  and  unrealized  gain for Fiscal 1997 was
comprised of a $3,972,372  net realized gain from the sale of certain  portfolio
investments  during the period,  as  discussed  below.  This gain was  partially
offset by a  $1,684,806  decrease to net  unrealized  appreciation  of portfolio
investments during Fiscal 1997, as discussed below.

The  $3,972,372  net gain  realized  during  Fiscal  1997 was  comprised  of the
following transactions:
     The Fund sold  12,500  common  shares of Accumed  International,  Inc.  and
warrants  to  purchase  250,000  shares of Accumed  common  stock for  $517,189,
realizing a gain of $444,872.  On April 23, 1996,  Shells  Seafood  Restaurants,
Inc.  completed its initial public  offering of common stock at $5.00 per share.
In connection  with the offering,  the Fund  received  $1,617,195,  representing
repayment  of  its  $1,310,000   senior  note  and  accrued  interest   thereon.
Additionally, in July 1996, the Fund sold its remaining investment in Shells for
$2,700,000,  realizing  a  gain  of  $2,110,000.  On  July  1,  1996,  the  Fund
transferred warrants to purchase 60,000 shares of
    Unigene  Laboratories,  Inc. common stock to certain individuals for payment
    of consulting and portfolio  transaction  costs incurred in connection  with
    the Fund's  investment in Unigene.  This transaction  resulted in a $105,000
    gain,  which was  equally  offset by  $105,000  of  consulting  fee  expense
    recorded by the Fund over several prior fiscal quarters.
     In July 1996, the Fund received $163,205 from  International  Communication
    Technologies,  Inc.,  representing repayment of the $150,000 note due to the
    Fund along with accrued interest thereon.
     In January 1997, the Fund sold its 150,000 common shares of Optiva Corp. in
     a private  transaction for  $1,800,000,  realizing a gain of $1,312,500.

The Fund's  $1,684,806 net decrease in net unrealized  appreciation of portfolio
investments  for Fiscal 1997 includes a $158,439 net unrealized  gain due to the
net upward  revaluation  of certain  portfolio  investments  during the  period,
primarily   Unigene   Laboratories,   Inc.  This  increase  to  net   unrealized
appreciation  of  investments  was  more  than  offset  by the net  transfer  of
$1,526,367  from  unrealized  gain to realized  gain  relating to the  portfolio
investments sold during Fiscal 1997, as discussed above.

Fiscal 1996:
The $1,060,252 net realized and unrealized gain for Fiscal 1996 was comprised of
a $1,061,009 net realized loss from the sale and write-off of certain  portfolio
investments  during the  period,  as  discussed  below.  This loss was more than
offset by a  $2,121,261  increase to net  unrealized  appreciation  of portfolio
investments for Fiscal 1996, as discussed below.

The  $1,061,009  net loss  realized  during  Fiscal  1996 was  comprised  of the
following transactions:
     In March 1995, the Fund sold its $250,000  investment in SR  Communications
Corp. for $200,000 and a $40,000  non-interest bearing promissory note. The Fund
realized  a $14,000  loss and  recorded  $4,000  of  interest  income  from this
transaction.  In May 1995,  the Fund sold its 337,500 common shares of Silverado
Foods, Inc. in a private transaction for $822,656, realizing a gain of $672,656.
In June 1995, the Fund wrote-off its investments in Radiator King International,
Inc. and  Weir-Jones  Marketing,  Inc. due to continued  business and  financial
difficulties  at these  companies.  The Fund  realized a loss of  $1,010,000  in
Fiscal 1996 from the write-off of these two investments.  In September 1995, the
Fund  sold its  55,555  common  shares  of YES!  Entertainment  Corporation  for
$305,538,  realizing a loss of $393,662.  In October 1995, the Fund sold 150,000
common shares of Accumed International, Inc. (formerly Alamar Biosciences, Inc.)
for $159,375,  realizing a loss of $128,081. In November 1995, the Fund received
$145,728 for the  redemption  of its 291,456  common  stock  warrants of Regency
Holdings  (Cayman) Inc.,  resulting in a realized gain of $145,728.  In December
1995,  the Fund sold its  $1,200,000  promissory  note and  warrant to  purchase
900,000  common  shares  of  Bennett  Environmental  U.S.,  Inc.  in  a  private
transaction  for $820,000 and 450,000  common  shares of Bennett  Environmental.
This transaction resulted in a realized loss of $333,650 for Fiscal 1996.
The Fund's  $2,121,261 net increase in net unrealized  appreciation of portfolio
investments for Fiscal 1996 includes a $1,850,261 net unrealized gain due to the
net  upward  revaluation  of  certain  portfolio  investments  during  the year,
primarily Shells Seafood  Restaurants,  Inc., which completed its initial public
offering in April 1996. Net  unrealized  appreciation  of portfolio  investments
also  increased  due to the net  transfer of $271,000  from  unrealized  loss to
realized loss relating to the portfolio  investments sold or written-off  during
Fiscal 1996, as discussed above.

Investment Income and Expenses
For the 1997 Period,  the Trust had a net investment loss (interest and dividend
income less  operating  expenses) of $173,067.  For Fiscal 1997 and Fiscal 1996,
the Fund had a net investment loss of $1,243,927 and $313,174, respectively.

The significantly reduced net investment loss of $173,067 for the 1997 Period as
compared to $1,243,927 for Fiscal 1997 primarily reflects the termination of the
ongoing  operations  of the Fund,  the adoption of its Plan of  Liquidation  and
transfer of its remaining assets to the Trust, as discussed above.

Total  investment  income  for the 1997  Period  was  $304,556  as  compared  to
$1,692,225 for Fiscal 1997. The decrease in investment  income primarily was due
to the  recognition of $1,150,000 of other income during Fiscal 1997 relating to
a litigation settlement,  as discussed in detail in Note 4 of Notes to Financial
Statements.  Additionally,  interest  income  from  short-term  investments  was
reduced by  $180,381,  reflecting  the shorter 1997 Period of  approximately  10
months  compared to the almost  complete  full year period for Fiscal 1997,  and
reduced cash equivalent  balances held during the 1997 Period as compared to the
amount for Fiscal  1997.  Interest  income is expected to continue to decline as
the Trust continues with the liquidation of its remaining  assets and subsequent
distribution  of such  proceeds  to Unit  holders.  The Trust had no interest or
dividend income from portfolio investments for the 1997 Period, since it held no
interest earning portfolio securities during the 1997 Period.

The  operating  expenses  of the  Trust for the 1997  Period  were  $477,623  as
compared to  $2,936,152  for Fiscal 1997.  The  decrease in  operating  expenses
primarily is attributable to two major factors. First, a significant decrease in
legal fees was incurred  during the 1997 Period  compared to Fiscal 1997.  Legal
fees incurred during Fiscal 1997 totaled $1,991,383, as compared to $167,602 for
the 1997 Period.  The Fund  incurred  significant  legal fees during Fiscal 1997
from (i)  several  legal  proceedings  involving  the Fund (see Notes 4 and 5 of
Notes to Financial Statements),  (ii) continued  restructuring of certain of the
Fund's portfolio  investments  during Fiscal 1997, (iii) matters relating to the
Fund's July 23, 1996 special meeting of shareholders and Plan of Liquidation and
(iv)  preparation  and  issuance of the  Information  Statement  relating to the
establishment of the Trust.  Secondly,  certain operating  expenses of the Fund,
other than legal  fees,  are no longer  incurred  by the Trust.  These  expenses
include  salary  expense,   amortization  expense,  directors  fees,  insurance,
consulting  fees and certain other  expenses.  Expenses,  other than legal fees,
incurred  for the 1997 Period  totaled  $310,021,  as  compared to $944,769  for
Fiscal 1997.

The increase in net investment  loss for Fiscal 1997 compared to Fiscal 1996 was
due to a $1,772,508 increase in operating  expenses,  which exceeded an $841,755
increase in investment  income.  The increase in operating expenses primarily is
attributable  to the  significant  increase in legal fees during Fiscal 1997, as
discussed  above.  The $841,755  increase in  investment  income for Fiscal 1997
compared to Fiscal 1996  primarily is due to the  recognition  of  $1,150,000 of
other income  relating to a litigation  settlement,  as  discussed  above.  This
income was  partially  offset by a decline in interest and dividend  income from
portfolio  investments of $369,271 due to the reduced amount of interest earning
portfolio  securities  held by the Fund during Fiscal 1997 as compared to Fiscal
1996.

Net Assets
For the 1997 Period,  the Trust had a $424,660  decrease in net assets resulting
from operations, comprised of the $251,593 net realized and unrealized loss from
portfolio  investments  and the $173,067 net  investment  loss.  The Trust's net
assets  also were  reduced  by the  $2,427,281  cash  distribution  made to unit
holders on July 15, 1997. As a result, the Trust's net assets were $6,931,370 at
December  31, 1997,  representing  a decrease of  $2,851,941  from net assets of
$9,783,311 at February 24, 1997, the Fund's termination date.

On a per Unit basis, the results of operations for the 1997 Period decreased the
Trust's  net  assets  by $.17 per Unit  and the cash  distribution  paid to Unit
holders on July 15, 1997 reduced the Trust's net assets by $1.00 per Unit.  As a
result,  the Trust's net asset value was $2.86 per Unit as of December 31, 1997,
down $1.17 from $4.03 as of February 24, 1997.

Summary of Portfolio Transaction and Change in Net Assets during the 1997 Period

Portfolio transactions completed during the 1997 Period,  resulted in a realized
gain of $775,250.  As shown below, these  transactions  returned $822,500 to the
Trust and  increased  its net  asset  value for the  period  by  $371,845.  This
increase  in the  Trust's  net  assets was more than  offset by a  $623,438  net
decrease in net assets  resulting  from the downward  revaluation of the Trust's
investment  in  Unigene  Laboratories,  Inc.,  as  shown  below.  The  completed
portfolio transactions and revaluations decreased the Trust's net asset value on
a net basis by $251,593 for the 1997 Period.

<TABLE>
                                                                                                         Effect on
                                                      1997 Period              Fair Value                 Net Assets
Investment                                             Proceeds                at 2/24/97             for the 1997 Period
- -------------------------------------------------------------------------------------------------------------------------
Sales during the 1997 period:
- ----------------------------
<S>                                                     <C>                       <C>                       <C>            
Unigene Laboratories, Inc.                         $       440,000           $      358,750            $        81,250
Bennett Environmental, Inc.                                382,500                   91,905                    290,595
                                                   ---------------           --------------            ---------------
Sub-total from sales                               $       822,500           $      450,655                    371,845
                                                   ===============           ==============            ---------------


Revaluations during the 1997 period:
Unigene Laboratories, Inc. (Warrants)                                                                              (623,438)
Sub-total from portfolio transactions                                                                              (251,593)

Net investment loss for the 1997 Period                                                                            (173,067)
                                                                                                            ---------------
Change in Net Assets for the 1997 Period                                                                    $      (424,660)
                                                                                                            ===============
</TABLE>


For  Fiscal  1997,  the Fund had a net  increase  in net assets  resulting  from
operations of $1,043,639, comprised of the net realized and unrealized gain from
portfolio  investments  of  $2,287,566  offset  by the  net  investment  loss of
$1,243,927.  Additionally,  the cash distribution paid to shareholders on August
30, 1996 also  reduced  the Fund's net assets by  $8,495,486.  As a result,  the
Fund's net assets were $9,783,311,  or $4.03 per common  equivalent share, as of
February 24, 1997, down from $17,235,158,  or $7.25 per common equivalent share,
as of February 29, 1996.

For  Fiscal  1996,  the Fund had a net  increase  in net assets  resulting  from
operations of $747,078,  comprised of the net realized and unrealized  gain from
portfolio  investments  of  $1,060,252  offset  by the  net  investment  loss of
$313,174.  This  increase was more than offset by a  $1,226,993  decrease in net
assets  resulting  from the  repurchase by the Fund of 290,227 shares of its own
common stock in the public market  during  Fiscal 1996. As a result,  the Fund's
net assets decreased  $479,915 to $17,235,158 at February 29, 1996, or $7.25 per
common equivalent share.


<PAGE>



Item 8.  Financial Statements and Supplementary Data.



                           MICROCAP LIQUIDATING TRUST
                     (Successor to The MicroCap Fund, Inc.)
                                      INDEX


Independent Auditors' Report

Statements  of Assets and  Liabilities  as of December 31, 1997 and February 24,
1997 (Date of Termination) (Predecessor)

Schedules of Portfolio Investments as of December 31, 1997 and February 24, 1997
(Date of Termination) (Predecessor)

Statements of  Operations  for the period from February 25, 1997 to December 31,
1997,  for the  period  from  March  1,  1996 to  February  24,  1997  (Date  of
Termination)  (Predecessor)  and for the fiscal  year ended  February  29,  1996
(Predecessor)

Statements  of Changes in Net Assets for the period  from  February  25, 1997 to
December 31, 1997,  for the period from March 1, 1996 to February 24, 1997 (Date
of  Termination)  (Predecessor)  and for the fiscal year ended February 29, 1996
(Predecessor)

Statements  of Cash Flows for the period from  February 25, 1997 to December 31,
1997,  for the  period  from  March  1,  1996 to  February  24,  1997  (Date  of
Termination)  (Predecessor)  and for the fiscal  year ended  February  29,  1996
(Predecessor)

Notes to Financial Statements

Note     - All schedules are omitted because of the absence of conditions  under
         which they are required or because the required information is included
         in the financial statements or notes thereto.



<PAGE>


INDEPENDENT AUDITORS' REPORT




MicroCap Liquidating Trust

We have audited the accompanying statements of assets and liabilities, including
the schedules of portfolio  investments,  of the MicroCap Liquidating Trust (the
"Trust") as of December 31, 1997 and The MicroCap Fund,  Inc. (the "Fund") as of
February  24,  1997  (Date  of  Termination),  and  the  related  statements  of
operations,  changes  in net  assets  and cash flows of the Trust for the period
from February 25, 1997 to December 31, 1997 and for the Fund for the period from
March 1, 1996 to February 24, 1997 (Date of Termination)  and for the year ended
February 29, 1996.  These  financial  statements are the  responsibility  of the
Trust's and the Fund's  management.  Our responsibility is to express an opinion
on these financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. Our procedures included
confirmation  of securities  owned at December 31, 1997 and February 24, 1997 by
correspondence  with  the  custodian.  An  audit  also  includes  assessing  the
accounting principles used and significant estimates made by management, as well
as evaluating the overall financial statement presentation.  We believe that our
audits provide a reasonable basis for our opinion.

In our  opinion,  such  financial  statements  present  fairly,  in all material
respects,  the financial position of the Trust at December 31, 1997 and the Fund
at  February  24,  1997 (Date of  Termination)  and the  results of the  Trust's
operations,  changes in net assets and cash flows for the period  from  February
25, 1997 to December 31, 1997 and for the Fund for the period from March 1, 1996
to February 24, 1997 (Date of  Termination)  and for the year ended February 29,
1996 in conformity with generally accepted accounting principles.

As explained in Note 2, the financial  statements  include  securities valued at
$1,622,500  and  $2,696,593  at December 31, 1997 and February 24, 1997 (Date of
Termination),   respectively,   representing   23%  and   28%  of  net   assets,
respectively, whose values have been estimated by the Trustee of the Trust as of
December  31, 1997 and by the Board of  Directors of the Fund as of February 24,
1997 in the absence of readily ascertainable market values. We have reviewed the
procedures  used by the  Trustee and the Board of  Directors  in arriving at the
estimated value of such securities and have inspected underlying  documentation,
and, in the  circumstances,  we believe the  procedures  are  reasonable and the
documentation  appropriate.  However,  because of the  inherent  uncertainty  of
valuation,  those estimated values may differ significantly from the values that
would have been used had a ready  market  for the  securities  existed,  and the
differences could be material.



Deloitte & Touche LLP

New York, New York
February 20, 1998


<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
STATEMENTS OF ASSETS AND LIABILITIES
As of December 31, 1997 and February 24, 1997 (Date of Termination)


<TABLE>
                                                                                                                 February 24,
                                                                                             December 31,      1997
                                                                                                 1997            (Predecessor)
ASSETS

Portfolio investments at fair value (cost $2,177,500 at December 31,
<S>              <C>                    <C> <C>                                             <C>                <C>             
   1997 and cost $2,224,750 at February 24, 1997)                                           $     1,622,500    $      2,696,593
Cash and cash equivalents - unrestricted                                                          2,651,802           4,781,028
Cash and cash equivalents - restricted                                                            2,790,218           2,790,218
Accrued interest receivable                                                                          18,644              25,959
Receivable from settlement agreement                                                                      -             650,000
Other assets                                                                                            883              24,846
                                                                                            ---------------    ----------------
   Total assets                                                                                   7,084,047          10,968,644
                                                                                            ---------------    ----------------

LIABILITIES

Accounts payable - legal                                                                             87,015           1,076,982
Accounts payable - other                                                                             65,662             108,351
                                                                                            ---------------    ----------------
   Total liabilities                                                                                152,677           1,185,333
                                                                                            ---------------    ----------------

NET ASSETS IN LIQUIDATION                                                                   $     6,931,370    $      9,783,311
                                                                                            ===============    ================


Net assets per Unit of beneficial interest or
   common equivalent share                                                                       $     2.86         $    4.03
                                                                                                 ==========         =========

Number of Units of beneficial interest or
   common equivalent share                                                                        2,427,281          2,427,281
                                                                                                  =========          =========
</TABLE>






See notes to financial statements.


<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
SCHEDULE OF PORTFOLIO INVESTMENTS
As of December 31, 1997
<TABLE>
                                                                                                                         % of
Issuer / Position                                                                   Cost              Fair Value       Net Assets(1)

Publicly-Held Securities: (A)

Unigene Laboratories, Inc. (B)
Warrant to purchase 475,000 shares of Common Stock
<S>   <C>              <C> <C>                                                  <C>                 <C>                  <C>  
   at $1.375, expiring 7/7/00                                                   $           0       $      593,750       8.57%
                                                                                -------------       --------------     -------

YES! Entertainment Corporation
Warrant to purchase 11,437 shares of Common Stock
   at $15.30 per share, expiring 7/16/98                                                    0                    0           0%
                                                                                -------------       --------------   ----------

Privately-Held Securities:

First Colony Acquisition Corp. (C)
106,562 shares of Series A1 Preferred Stock                                           594,174              297,087
240,179 shares of Series B1 Preferred Stock                                         1,343,326              671,663
Warrant to purchase 7,560 shares of Common Stock
   at $5.00, expiring 1/24/00                                                               0                    0
                                                                                -------------       --------------
                                                                                    1,937,500              968,750      13.98%
                                                                                -------------       --------------    --------
Oh-La-La! Inc.
9% Convertible Senior Note                                                            140,000               34,800
9% Convertible Senior Note                                                            100,000               25,200
                                                                                -------------       --------------
                                                                                      240,000               60,000     .87%
                                                                                -------------       -----------------------

Total Portfolio Investments(D)                                                  $   2,177,500       $    1,622,500      23.42%
                                                                                =============       ==============    ========
</TABLE>



(1) Represents fair value as a percentage of net assets.

(A)  In November  1997, the Trust sold its remaining  investment in Bennett  
     Environmental,  Inc. for net proceeds of $382,500,  or $3.40 per
     share. The Trust realized a net gain of $335,250 as a result of this 
     transaction.

(B)  In June 1997,  the Trust sold a covered call option for  $37,500,  allowing
     for  the  purchase  of up to  307,500  common  stock  warrants  of  Unigene
     Laboratories, Inc. at a purchase price of $2.875 per warrant. In July 1997,
     a portion of the option was  exercised  for 140,000  warrants at $2.875 per
     warrant,  or $402,500.  The remaining portion of the option expired on July
     30,  1997.  The Trust  realized a net gain of $440,000 as a result of these
     transactions.

(C)  On  July  31,  1997,  due to a  financial  restructuring  of  First  Colony
     Acquisition Corp., the Trust's convertible 6% promissory note was exchanged
     for 240,179 shares of the company's Series B1 preferred stock.

(D) All portfolio securities held at December 31, 1997 are non-income producing.


     See notes to financial statements.





<PAGE>


THE MICROCAP FUND, INC. (Predecessor)
SCHEDULE OF PORTFOLIO INVESTMENTS
As of February 24, 1997 (Date of Termination)


<TABLE>
                                                                                                                            % of
Issuer / Position                                                                 Cost              Fair Value        Net Assets(1)

Publicly-Held Securities:

Bennett Environmental Inc.
<S>                                                                              <C>                <C>                   <C> 
112,500 shares of Common Stock                                                   $     47,250       $       91,905        .94%
                                                                                -------------       --------------

Unigene Laboratories, Inc.
Warrant to purchase 615,000 shares of Common Stock
   at $1.375, expiring 7/7/00                                                               0            1,575,938      16.11%
                                                                                -------------       --------------

YES! Entertainment Corporation
Warrant to purchase 11,437 shares of Common Stock
   at $15.30 per share, expiring 7/16/98                                                    0                    0           0%
                                                                                -------------       --------------


Privately-Held Securities:

First Colony Acquisition Corp.
106,562 shares of Preferred Stock                                                     594,174              297,087
6% Convertible Promissory Note due 11/1/97                                          1,343,326              671,663
Warrant to purchase 7,560 shares of Common Stock
   at $5.00, expiring 1/24/00                                                               0                    0
                                                                                -------------       --------------
                                                                                    1,937,500              968,750       9.90%
                                                                                -------------       --------------
Oh-La-La! Inc.
9% Convertible Senior Note                                                            140,000               34,800
9% Convertible Senior Note                                                            100,000               25,200
                                                                                -------------       --------------
                                                                                      240,000               60,000     .61%
                                                                                -------------       -------------- --------

Total Portfolio Investments                                                     $   2,224,750       $    2,696,593      27.56%
                                                                                =============       ==============      ======
</TABLE>


(1) Represents fair value as a percentage of net assets.


See notes to financial statements.


<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
STATEMENTS OF OPERATIONS
For the Period from  February  25, 1997 to December  31, 1997 and for the Period
from March 1, 1996 to February 24, 1997 (Date of Termination) and for the Fiscal
Year Ended February 29, 1996

<TABLE>
                                                                                                             Fiscal Year
                                                                   February 25,      March 1, 1996         Ended
                                                                      1997 to          to February 24,      February 29,
                                                                   December 31,      1997                  1996
                                                                       1997             (Predecessor)       (Predecessor)
INVESTMENT INCOME AND EXPENSES

Income:
   Interest from U.S. Treasury Bills and
<S>                                                               <C>                 <C>                  <C>          
      repurchase agreements                                       $      270,147      $      450,528       $     444,621
   Interest and dividends from portfolio
      investments                                                              -              36,578             405,849
   Other interest income                                                  15,467                   -                   -
   Other income                                                           18,942           1,205,119                   -
                                                                  --------------      --------------       -------------
   Total income                                                          304,556           1,692,225             850,470
                                                                  --------------      --------------       -------------

Expenses:
   Administrative expenses                                                73,498             125,741             167,113
   Legal fees                                                            167,602           1,991,383             384,993
   Accounting fees                                                        63,825              96,805              61,169
   Trustee fees                                                          148,035             127,319                   -
   Transfer agent and custodian fees                                      17,461              22,392              23,332
   Mailing and printing                                                    4,677              66,972              16,308
   Other operating expenses                                                2,525              89,012              46,163
   Salary expense                                                              -             178,919             328,901
   Amortization of deferred
      organizational costs                                                     -              80,608              39,372
   Directors' fees and expenses                                                -              47,879              13,665
   Consulting fees                                                             -              74,400              56,103
   Insurance expense                                                           -              34,722              26,525
                                                                  --------------      --------------       -------------
   Total expenses                                                        477,623           2,936,152           1,163,644
                                                                  --------------      --------------       -------------

NET INVESTMENT LOSS                                                     (173,067)         (1,243,927)           (313,174)
                                                                  --------------      --------------       -------------

NET REALIZED AND UNREALIZED GAIN
   (LOSS) FROM PORTFOLIO INVESTMENTS

   Net realized gain (loss) from portfolio
     investments                                                         775,250           3,972,372          (1,061,009)
   Change in net unrealized appreciation or
     (depreciation) of investments                                    (1,026,843)         (1,684,806)          2,121,261
                                                                  --------------      --------------       -------------
   Net realized and unrealized (loss) gain
     from portfolio investments                                         (251,593)          2,287,566           1,060,252
                                                                  --------------      --------------       -------------

NET (DECREASE) INCREASE IN NET ASSETS
   RESULTING FROM OPERATIONS                                      $     (424,660)     $    1,043,639       $     747,078
                                                                  ==============      ==============       =============
</TABLE>

See notes to financial statements.


<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
STATEMENTS OF CHANGES IN NET ASSETS
For the Period from  February  25, 1997 to December  31, 1997 and for the Period
from March 1, 1996 to February 24, 1997 (Date of Termination) and for the Fiscal
Year Ended February 29, 1996


<TABLE>
                                                                                           March 1,            Fiscal Year
                                                                     February 25,      1996 to              Ended
                                                                        1997 to          February 24,         February 29,
                                                                     December 31,      1997                 1996
                                                                         1997            (Predecessor)         (Predecessor)

Change in net assets resulting from operations:

<S>                                                               <C>                  <C>                  <C>             
Net investment loss                                               $       (173,067)    $     (1,243,927)    $      (313,174)
Net realized gain (loss) from portfolio investments                        775,250            3,972,372          (1,061,009)
Change in net unrealized appreciation or (depreciation)
   of portfolio investments                                             (1,026,843)          (1,684,806)          2,121,261
                                                                  ----------------     ----------------     ---------------
Net (decrease) increase in net assets resulting from
   operations                                                             (424,660)           1,043,639             747,078
                                                                  ----------------     ----------------     ---------------

Change in net assets from distributions:

Cash distributions paid                                                 (2,427,281)          (8,495,486)                  -
                                                                  ----------------     ----------------     ---------------

Change in net assets from capital stock transactions:

Common stock repurchased                                                         -                    -          (1,226,993)
                                                                  ----------------     ----------------     ---------------

Net decrease in net assets for the period                               (2,851,941)          (7,451,847)           (479,915)

Net assets in liquidation at beginning of period                         9,783,311           17,235,158          17,715,073
                                                                  ----------------     ----------------     ---------------

NET ASSETS IN LIQUIDATION AT
END OF PERIOD                                                     $      6,931,370     $      9,783,311     $    17,235,158
                                                                  ================     ================     ===============

Net assets per Unit of beneficial interest or
   common equivalent share                                               $   2.86             $   4.03              $  7.25
                                                                         ========             ========              =======

Number of Units of beneficial interest or
   common equivalent shares                                              2,427,281            2,427,281           2,376,609
                                                                     =============       ==============       =============
</TABLE>




See notes to financial statements.


<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
STATEMENTS OF CASH FLOWS
For the Period from  February  25, 1997 to December  31, 1997 and for the Period
from March 1, 1996 to February 24, 1997 (Date of Termination) and for the Fiscal
Year Ended February 29, 1996


<TABLE>
                                                                                          March 1,           Fiscal Year
                                                                     February 25      1996 to             Ended
                                                                       1997 to          February 24,        February 29,
                                                                    December 31,      1997                1996
                                                                         1997           (Predecessor)       (Predecessor)

CASH FLOWS USED FOR
   OPERATING ACTIVITIES

<S>                                                               <C>                 <C>                 <C>            
Net investment loss                                               $      (173,067)    $   (1,243,927)     $     (313,174)
Adjustments to reconcile net investment loss
   to cash used for operating activities:
(Decrease) increase in accounts payable and other liabilities     (1,032,656)         851,780             (5,814)
Decrease (increase) in accounts receivable and other assets               668,557           (130,265)            (41,763)
Depreciation expense                                                       12,721              5,103                 480
Amortization of deferred organizational costs                                   -             80,608              39,372
Amortization of discount on accounts receivable                                 -                  -              (4,000)
                                                                  ---------------     --------------      --------------
Cash flows used for operating activities                                 (524,445)          (436,701)           (324,899)
                                                                  ---------------     --------------      --------------

CASH FLOWS PROVIDED FROM
   INVESTING ACTIVITIES

Net proceeds from the sale of portfolio investments                       822,500          4,676,564           2,393,922
Repayment of notes                                                              -          2,000,000           3,940,000
Purchase of portfolio investments                                               -            (51,411)         (3,937,500)
                                                                  ---------------     --------------      --------------
Cash flows provided from investing activities                             822,500          6,625,153           2,396,422
                                                                  ---------------     --------------      --------------

CASH FLOWS USED FOR FINANCING
   ACTIVITIES

Cash distributions paid                                                (2,427,281)        (8,495,486)                  -
Common stock repurchased                                                        -                  -          (1,226,993)
                                                                  ---------------     --------------      --------------
Cash flows used for financing activities                               (2,427,281)        (8,495,486)         (1,226,993)
                                                                  ---------------     --------------      --------------

(Decrease) increase in cash and cash equivalents                       (2,129,226)        (2,307,034)            844,530
Cash and cash equivalents at beginning of period                        7,571,246          9,878,280           9,033,750
                                                                  ---------------     --------------      --------------

CASH AND CASH EQUIVALENTS AT END
   OF PERIOD                                                      $     5,442,020     $    7,571,246      $    9,878,280
                                                                  ===============     ==============      ==============
</TABLE>

See notes to financial statements.


<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
NOTES TO FINANCIAL STATEMENTS

1.     Organization and Purpose

The MicroCap  Liquidating  Trust (the "Trust"),  a liquidating trust established
under the laws of the State of New York, is the successor to the MicroCap  Fund,
Inc., formerly Commonwealth Associates Growth Fund, Inc. (the "Fund"). The Fund,
which  was  a  Maryland   corporation   formed  on  January  26,  1993,   was  a
non-diversified,  closed-end  management  investment  company and  operated as a
business  development  company  under the  Investment  Company Act of 1940.  The
Fund's investment  objective was to achieve  long-term  capital  appreciation of
assets,  rather than current income,  by investing in debt and equity securities
of  emerging  and  established   companies  that  management   believed  offered
significant growth potential.

Pursuant to its Plan of Liquidation,  which was approved at a special meeting of
shareholders on July 23, 1996, the Fund  transferred all of its remaining assets
and its remaining fixed and contingent liabilities to the Trust, effective as of
the close of business on February 24, 1997, the Fund's termination date.

Also  effective as of the close of business on February 24, 1997,  the 2,188,085
common  shares and 191,357  preferred  shares of the Fund,  outstanding  on such
date,  were  automatically  deemed to represent  2,427,281  units of  beneficial
interest  in the Trust  ("Units").  As a result,  on  February  24,  1997,  each
shareholder  of the Fund  received  one Unit of the Trust for each  share of the
Fund's common stock held on such date and 1.25 Units of the Trust for each share
of the Fund's preferred stock held on such date.

 2.   Significant Accounting Policies

Valuation of  Investments - Portfolio  investments  are carried at fair value as
determined  quarterly  by the  Trustee.  The fair  value  of each  publicly-held
portfolio  security is adjusted to the closing  public  market price on the last
day of the  calendar  quarter  discounted  by a  factor  of 0% to 20% for  sales
restrictions,  if any. Factors considered in the determination of an appropriate
discount include:  underwriter lock-up,  affiliate status by owning greater than
10% of the  outstanding  shares of a  portfolio  security,  and other  liquidity
factors such as the size of the Trust's  position in a given  portfolio  company
compared to the trading history of the public security. Privately-held portfolio
securities  are carried at cost until  significant  developments  affecting  the
portfolio company provide a basis for change in valuation, including adjustments
to reflect meaningful third-party transactions in the private market.

Use of Estimates - The  preparation of financial  statements in conformity  with
generally accepted  accounting  principles requires management to make estimates
and assumptions  that affect the reported  amounts of assets and liabilities and
disclosure of  contingent  assets and  liabilities  at the date of the financial
statements  and the  reported  amounts  of  revenues  and  expenses  during  the
reporting period. Actual results could differ from those estimates.

Investment  Transactions  - Realized  gains and losses on  investments  sold are
computed on a specific  identification basis. The Trust records its transactions
on the accrual method.

Income Taxes - The Trust is a complete  pass-through  entity for federal  income
tax  purposes  and,  accordingly,  is not subject to income tax.  Instead,  each
beneficiary  of the Trust is required to take into account,  in accordance  with
such  beneficiary's  method of accounting,  such beneficiary's pro rata share of
the Trust's income, gain, loss,  deduction or expense,  regardless of the amount
or timing of distributions to beneficiaries.



<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
NOTES TO FINANCIAL STATEMENTS - continued

Cash and  Cash  Equivalents  - The  Trust  invests  its  available  cash in U.S.
Treasury Bills and overnight repurchase agreements  collateralized by securities
issued by the U.S.  Government or its agencies.  Such investments are considered
to be cash equivalents for the statement of cash flows.

The  cash  and  cash  equivalents  of  the  Trust  include  restricted  cash  of
approximately  $2.8 million,  comprised of $2.4 million  relating to the Regency
Holdings (Cayman) Inc. litigation,  $250,000 relating to certain indemnification
agreements with Mr. Raymond S. Troubh,  the Trustee of the Trust, and certain of
the Fund's former directors and officers and $120,000  relating to the potential
reimbursement  of  out-of-pocket  expenses  of  a  shareholder  group  that  had
solicited  proxies in opposition to the Fund's Plan of Liquidation.  See Notes 4
and 5 below.
     Reclassifications - Certain reclassifications were made to the prior period
financial statements in order to conform to the current period -----------------
presentation.

3.     Related Party Transactions
In July 1996, the Fund entered into an agreement with Raymond S. Troubh, whereby
Mr. Troubh provided  management services to the Fund in connection with its Plan
of  Liquidation  and has  continued to provide such services to the Trust during
its liquidation.  For services rendered under the agreement, Mr. Troubh receives
$8,500 per month,  plus 1% of the amount of each  distribution  (other  than the
initial  distribution paid by the Fund on August 30, 1996), plus a percentage of
any  proceeds  of sale or other  revenues  received  by the Fund or the Trust in
excess of the investment in the particular asset. Mr. Troubh was paid 5% of such
excess for amounts  received in 1996 and 1997 and will be paid 4% in 1998, 2% in
1999 and 0% thereafter.

During the periods  reported for the Fund, each  non-affiliated  director of the
Fund's  Board of  Directors  received  an annual fee of $2,500 and $250 for each
meeting  of the Board of  Director's  and each  committee  meeting  of the Board
attended.  Each  non-affiliated  director  also received  reimbursement  for all
out-of-pocket costs incurred to attend such meetings.

4.     Litigation
On April 19, 1996, the Fund filed a complaint against Commonwealth Associates, a
registered  broker-dealer  and the  underwriter  of the  Fund's  initial  public
offering,   Michael  S.  Falk,  the  chief  executive  officer  of  Commonwealth
Associates,  a minority shareholder and former director of the Fund, and Stephen
J. Warner, a former executive officer of Commonwealth  Associates and the former
president of the Fund. The civil action, which was filed in federal court in the
Southern  District of New York,  alleged fraud,  breach of fiduciary  duties and
violations of the Investment Company Act of 1940. On December 24, 1996, the Fund
and the defendants agreed to a settlement of the complaint, whereby Commonwealth
Associates  made  settlement  payments  to  the  Fund  and  the  Trust  totaling
$1,150,000. In connection therewith, the Fund received $500,000 in December 1996
and an additional  $650,000 in installments during 1997. Interest of $20,415 was
also paid to the Trust with the final  installment  payment in December 1997. As
part of the  settlement,  the Fund and the  defendants  agreed to pursue  claims
against  former counsel to the Fund. The Trust is entitled to receive 50% of any
recovery from such claims after reimbursement to Commonwealth  Associates of all
costs and expenses associated with pursuing the claims.
     The Trust is a creditor of PSSS, Inc.,  formerly  Oh-La-La!  Inc. ("PSSS"),
which is the  subject of  proceedings  under  Chapter  11 of the  United  States
Bankruptcy Code pending in San Francisco, California (the "Bankruptcy Case"). In
connection   with   the   Bankruptcy   Case,   Oh-La-La!   International,   S.A.
("International"), one of PSSS's largest shareholders, has filed a precautionary
proof of claim (the

<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
NOTES TO FINANCIAL STATEMENTS - continued

"Precautionary  Proof of Claim"), on behalf of International and other similarly
situated  shareholders of PSSS, against,  among others, the Trust, certain other
creditors of PSSS, and parties  involved in the intended  underwriting  for, and
conduct of, an initial  public  offering which PSSS had  anticipated  would have
occurred in or about 1994. The Precautionary  Proof of Claim alleges a claim for
damages as a result of, among other things,  (a) the failure to  effectuate  the
intended initial public offering, and (b) the Bankruptcy  Court-approved sale of
PSSS's assets, which was allegedly prejudicial to PSSS's shareholders.  PSSS and
International  have taken no other action regarding this claim. The Trust denied
liability for the claims set forth in the Precautionary Proof of Claim. A global
settlement has been reached between and among PSSS, International, the Trust and
several  other  parties,  pursuant to which the Trust will have no liability for
the claims set forth in the Precautionary Proof of Claim (the "Settlement"). The
Settlement  has been  preliminarily  approved  by the  Bankruptcy  Court  and is
subject to final approval upon  confirmation  of a plan of liquidation for PSSS.
Recovery  on account of the Trust's  claims as a creditor of PSSS is  contingent
upon a number of factors beyond the Trust's control.

Regency  Holdings   (Cayman)  Inc.   ("Holdings")  and  Regency  Maritime  Corp.
("Maritime")  (collectively  "Regency")  along with other  related  entities are
debtors in a bankruptcy case pending in the United States  Bankruptcy  Court for
the Southern  District of New York, 95 B 45197 (TLB). In that  bankruptcy  case,
Regency  initiated an adversary  proceeding  against the Fund and certain  other
persons and entities to recover monies that it paid them on the ground that such
payments constituted  voidable  preferences or fraudulent  conveyances under the
Bankruptcy Code.  Holdings  maintains that a payment made to the Fund between 90
days and one year prior to the filing of  Regency's  bankruptcy  petition in the
amount of  $1,940,000  to satisfy a bridge loan the Fund made to  Regency,  is a
voidable preference because Kamal Mustafa, the former president of the Fund, was
a director of Regency (and  therefore an insider) for a portion of the time that
such amounts were due and owing.  Holdings also maintains that such relationship
had an  impact on the  decision  to pay these  amounts.  Additionally,  Holdings
maintains that a payment of $145,728 made to the Fund to redeem certain warrants
issued  with  respect  to the loan  transaction  was made  within 90 days of the
filing of the bankruptcy petition and is therefore a voidable preference without
regard to whether Mustafa was an insider.  The Fund has served an answer denying
the allegations of the amended complaint and is vigorously  contesting Regency's
claims.  Pursuant to an order filed with the Bankruptcy Court, the Trust has set
aside  approximately  $2.4 million in an  interest-bearing  cash account pending
resolution  by the  Bankruptcy  Court of the adversary  proceeding.  Substantial
discovery has been undertaken. A limited trial based upon written submissions to
address the validity of Regency's  preference  claims was held in December  1997
and  resulted in a judgment  in favor of the Trust,  dismissing  the  preference
claims with prejudice.  It is expected that a trial on the fraudulent conveyance
claims will be held during 1998.

5.     Other Information
On July 15, 1996,  the Fund entered into a settlement  agreement with a group of
shareholders of the Fund's common stock that had solicited proxies in opposition
to the  Fund's  Plan of  Liquidation  (the "13D  Group").  Under the  settlement
agreement,  the Fund and the 13D Group agreed that,  (i) certain  members of the
13D Group and affiliated  persons would cease to have business  dealings with or
receive compensation from the Fund, (ii) a 13D Group member would have the right
to receive  notice of and attend all meetings of the Board of Directors  and any
committee  meeting thereof,  and (iii) subject to the approval of the Securities
and Exchange Commission (the "SEC"), the Trust would reimburse the 13D Group for
its reasonable out of pocket  expenses up to $120,000 in connection with the 13D
Group's efforts.  An application  relating to such reimbursement by the Trust to
the 13D Group was filed with the SEC on September 27, 1996.



<PAGE>


MICROCAP LIQUIDATING TRUST
(Successor to The MicroCap Fund, Inc.)
NOTES TO FINANCIAL STATEMENTS - continued


Effective on August 1, 1996,  the Fund entered into  indemnification  agreements
with Mr. Raymond Troubh and certain of the Fund's former directors and officers.
Pursuant  to such  agreements,  the Fund  established  an  escrow  account  that
contains  approximately  $250,000  in cash or cash  equivalents  to provide  for
potential  legal fees and settlement  payments  relating to certain actions that
may arise against such individuals relating to activity involving the Fund.

6.     Cash Distributions

On August 30,  1996,  the Fund made an  initial  liquidating  cash  distribution
totaling  $8,495,486  to  shareholders  of  record on August  15,  1996.  Common
shareholders received $3.50 per share and preferred shareholders received $4.375
per share.  The amount paid to common  shareholders  was  comprised of $0.274 of
long-term  capital  gain and $3.226 of return of  capital.  The  amount  paid to
preferred  shareholders  was  comprised of $0.343 of long-term  capital gain and
$4.032 of return of capital.

On July 15 1997, the Trust paid an interim  liquidating  distribution  totaling
 $2,427,281,  or $1.00 per Unit, to unit holders of record on June 30, 1997.

7.     Classification of Portfolio Investments

The Trust's investments were categorized as follows as of December 31, 1997:

<TABLE>
                                                                                                          Percentage of
Type of Investments                                        Cost                   Fair Value                  Net Assets*
- -------------------                                   ---------------           ---------------               -----------
<S>                                                  <C>                         <C>                          <C>   
Preferred Stock                                      $      1,937,500            $      968,750               13.98%
Common Stock                                                        0                   593,750                8.57%
Debt Securities                                               240,000                    60,000              .87%
                                                     ----------------            --------------            ------

Total                                                $      2,177,500            $    1,622,500               23.42%
                                                     ================            ==============               ======

Country/Geographic Region
Western U.S.                                         $        240,000            $       60,000                 .87%
Eastern U.S.                                                1,937,500                 1,562,500               22.55%
                                                     ----------------            --------------               ------

Total                                                $      2,177,500            $    1,622,500               23.42%
                                                     ================            ==============               ======

Industry
Biotechnology                                        $              0            $      593,750                8.57%
Consumer Products                                           1,937,500                   968,750               13.98%
Food Services                                                 240,000                    60,000              .87%
                                                     ----------------            --------------           -------

Total                                                $      2,177,500            $    1,622,500               23.42%
                                                     ================            ==============               ======
</TABLE>


*    Represents fair value as a percentage of net assets.


<PAGE>


Item 9.       Disagreements on Accounting and Financial Disclosure.

None.

                                    PART III

Item 10.      Directors and Executive Officers.

The following table sets forth certain  information  with respect to the Trustee
of the Trust.

<TABLE>
                                              Year First
                                               Elected a
                                               Director                          Position with
Name                              Age         or Officer                           the Trust
<S>                               <C>            <C>                                       
Raymond S. Troubh                 71             1996                               Trustee
</TABLE>

Raymond S. Troubh  served as  President,  Chief  Executive  Officer,  Treasurer,
Secretary and Director of the Fund since July 1996, and has been the independent
Trustee of the Trust since its  formation on February 25, 1997.  Mr. Troubh is a
financial  consultant,  a former  governor of the American  Stock Exchange and a
former general  partner of Lazard Freres & Co., an investment  banking firm. Mr.
Troubh  is a  director  of  America  West  Airlines,  Inc.,  an  airline;  ARIAD
Pharmaceuticals,  Inc., a pharmaceutical company; Becton, Dickinson and Company,
a healthcare products manufacturer; Diamond Offshore Drilling, Inc., an offshore
drilling company; Foundation Health Systems, Inc., a healthcare company; General
American Investors Company, an investment advisory company;  Olsten Corporation,
a temporary personnel and healthcare services company; Petrie Stores Liquidating
Trust,  a  liquidating  trust  holding  the assets of a former  women's  apparel
retailer;  Time Warner Inc., a media and entertainment company; WHX Corporation,
a holding company; and Triarc Companies, Inc., a diversified holding company.

Item 11.      Executive Compensation.

On July 24, 1996,  following approval by the Board of Directors of the Fund, Mr.
Troubh entered into a consulting  agreement with the Fund and by extension,  the
Trust,  pursuant to which he is compensated  for his management  services to the
Trust  in the  amount  of  $8,500  per  month,  plus  1% of the  amount  of each
distribution  (other than the  initial  distribution  paid on August 30,  1996),
plus, a percentage  of any  proceeds of sale or other  revenues  received by the
Trust in excess of the Trust's  investment in a particular asset. Mr. Troubh was
paid 5% of such excess for amounts  received in 1996 and 1997,  and will be paid
4% in 1998, 2% in 1999, and 0% thereafter.  For the 1997 Period,  the Trust paid
fees to Mr. Troubh totaling $148,035.


<PAGE>


Item 12.      Security Ownership of Certain Beneficial Owners and Management.

Security Ownership

As of March 16, 1998, Mr. Troubh, the sole Trustee of the Trust, held no units 
of beneficial interest in the Trust.

Item 13.      Certain Relationships and Related Transactions.

Not applicable.

                                     PART IV

Item 14.      Exhibits, Financial Statements, Schedules and Reports on Form 8-K.

(a)  1.  Financial Statements

         Independent Auditors' Report

     Statements of Assets and  Liabilities  as of December 31, 1997 and February
24, 1997 (Date of Termination) Schedules of Portfolio Investments as of December
31, 1997 and February 24, 1997 (Date of Termination)
         Statements  of  Operations  for the period  from  February  25, 1997 to
         December  31,  1997,  for the period from March 1, 1996 to February 24,
         1997 (Date of  Termination)  and for the fiscal year ended February 29,
         1996

         Statements  of Changes in Net Assets for the period from  February  25,
         1997 to  December  31,  1997,  for the  period  from  March 1,  1996 to
         February 24, 1997 (Date of  Termination)  and for the fiscal year ended
         February 29, 1996

         Statements  of Cash  Flows for the period  from  February  25,  1997 to
         December  31,  1997,  for the period from March 1, 1996 to February 24,
         1997 (Date of  Termination)  and for the fiscal year ended February 29,
         1996

         Notes to Financial Statements

     2.  Exhibits.

         (2)        Agreement and Declaration of Trust,  dated as of January 28,
                    1997, between the Fund and Raymond S. Troubh as Trustee (1)

         (3)  (i)   Certificate of Incorporation of the Fund (2)

              (ii)  (a)   Bylaws of the Fund (2)

                    (b)   Amendments to Bylaws of the Fund (3)

         (27) Financial Data Schedule

(b) No reports on Form 8-K have been filed during the last quarter of the period
for which this report is filed.
- -----------------------
     (1)  Incorporated  by reference to the Fund's Form 10-K for the period from
March 1, 1996 to February 24, 1997,  filed on May 15, 1997. (2)  Incorporated by
reference  to the Fund's Form N-2, as amended,  filed on January 29,  1993.  (3)
Incorporated  by  reference  to the Fund's  Form 10-K for the fiscal  year ended
February 29, 1996, filed on June 13, 1996.

<PAGE>


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

              MICROCAP LIQUIDATING TRUST


                    /s/           Raymond S. Troubh
              Raymond S. Troubh
              Trustee


Date:         March 30, 1998

<TABLE> <S> <C>


<ARTICLE>                                                                      6
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE MICROCAP
LIQUIDATING  TRUST'S TRANSITION REPORT ON FORM 10-K FOR THE PERIOD FROM FEBRUARY
25, 1997 TO DECEMBER  31, 1997 AND IS  QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                                                                          <C>
<PERIOD-TYPE>                                                             12-MOS
<FISCAL-YEAR-END>                                                    DEC-31-1997
<PERIOD-START>                                                       FEB-25-1997
<PERIOD-END>                                                         DEC-31-1997
<INVESTMENTS-AT-COST>                                                  2,177,500
<INVESTMENTS-AT-VALUE>                                                 1,622,500
<RECEIVABLES>                                                             18,644
<ASSETS-OTHER>                                                               883
<OTHER-ITEMS-ASSETS>                                                   5,442,020
<TOTAL-ASSETS>                                                         7,084,047
<PAYABLE-FOR-SECURITIES>                                                       0
<SENIOR-LONG-TERM-DEBT>                                                        0
<OTHER-ITEMS-LIABILITIES>                                                152,677
<TOTAL-LIABILITIES>                                                      152,677
<SENIOR-EQUITY>                                                                0
<PAID-IN-CAPITAL-COMMON>                                                       0
<SHARES-COMMON-STOCK>                                                  2,427,281
<SHARES-COMMON-PRIOR>                                                          0
<ACCUMULATED-NII-CURRENT>                                                      0
<OVERDISTRIBUTION-NII>                                                         0
<ACCUMULATED-NET-GAINS>                                                        0
<OVERDISTRIBUTION-GAINS>                                                       0
<ACCUM-APPREC-OR-DEPREC>                                               (555,000)
<NET-ASSETS>                                                           6,931,370
<DIVIDEND-INCOME>                                                              0
<INTEREST-INCOME>                                                        285,614
<OTHER-INCOME>                                                            18,942
<EXPENSES-NET>                                                           477,623
<NET-INVESTMENT-INCOME>                                                (173,067)
<REALIZED-GAINS-CURRENT>                                                 775,250
<APPREC-INCREASE-CURRENT>                                            (1,026,843)
<NET-CHANGE-FROM-OPS>                                                  (424,660)
<EQUALIZATION>                                                                 0
<DISTRIBUTIONS-OF-INCOME>                                                      0
<DISTRIBUTIONS-OF-GAINS>                                                       0
<DISTRIBUTIONS-OTHER>                                                  2,427,281
<NUMBER-OF-SHARES-SOLD>                                                        0
<NUMBER-OF-SHARES-REDEEMED>                                                    0
<SHARES-REINVESTED>                                                            0
<NET-CHANGE-IN-ASSETS>                                               (2,851,941)
<ACCUMULATED-NII-PRIOR>                                                        0
<ACCUMULATED-GAINS-PRIOR>                                                      0
<OVERDISTRIB-NII-PRIOR>                                                        0
<OVERDIST-NET-GAINS-PRIOR>                                                     0
<GROSS-ADVISORY-FEES>                                                          0
<INTEREST-EXPENSE>                                                             0
<GROSS-EXPENSE>                                                                0
<AVERAGE-NET-ASSETS>                                                   8,357,341
<PER-SHARE-NAV-BEGIN>                                                       4.03
<PER-SHARE-NII>                                                            (.07)
<PER-SHARE-GAIN-APPREC>                                                    (.10)
<PER-SHARE-DIVIDEND>                                                           0
<PER-SHARE-DISTRIBUTIONS>                                                   1.00
<RETURNS-OF-CAPITAL>                                                           0
<PER-SHARE-NAV-END>                                                         2.86
<EXPENSE-RATIO>                                                                0
<AVG-DEBT-OUTSTANDING>                                                         0
<AVG-DEBT-PER-SHARE>                                                           0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission